- Home
- MGPI vs MNMD Comparison
MGPI vs MNMD Comparison
Compare MGPI & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGPI
- MNMD
- Stock Information
- Founded
- MGPI 1941
- MNMD 2019
- Country
- MGPI United States
- MNMD United States
- Employees
- MGPI N/A
- MNMD N/A
- Industry
- MGPI Beverages (Production/Distribution)
- MNMD Pharmaceuticals and Biotechnology
- Sector
- MGPI Consumer Staples
- MNMD Health Care
- Exchange
- MGPI Nasdaq
- MNMD Nasdaq
- Market Cap
- MGPI 610.9M
- MNMD 709.9M
- IPO Year
- MGPI 1988
- MNMD N/A
- Fundamental
- Price
- MGPI $27.57
- MNMD $9.57
- Analyst Decision
- MGPI Strong Buy
- MNMD Strong Buy
- Analyst Count
- MGPI 5
- MNMD 7
- Target Price
- MGPI $45.40
- MNMD $24.71
- AVG Volume (30 Days)
- MGPI 186.0K
- MNMD 1.1M
- Earning Date
- MGPI 10-30-2025
- MNMD 11-06-2025
- Dividend Yield
- MGPI 1.75%
- MNMD N/A
- EPS Growth
- MGPI N/A
- MNMD N/A
- EPS
- MGPI N/A
- MNMD N/A
- Revenue
- MGPI $609,404,000.00
- MNMD N/A
- Revenue This Year
- MGPI N/A
- MNMD N/A
- Revenue Next Year
- MGPI N/A
- MNMD N/A
- P/E Ratio
- MGPI N/A
- MNMD N/A
- Revenue Growth
- MGPI N/A
- MNMD N/A
- 52 Week Low
- MGPI $25.12
- MNMD $4.70
- 52 Week High
- MGPI $86.35
- MNMD $11.02
- Technical
- Relative Strength Index (RSI)
- MGPI 40.60
- MNMD 51.80
- Support Level
- MGPI $27.50
- MNMD $8.70
- Resistance Level
- MGPI $28.45
- MNMD $9.95
- Average True Range (ATR)
- MGPI 0.81
- MNMD 0.52
- MACD
- MGPI -0.12
- MNMD -0.01
- Stochastic Oscillator
- MGPI 7.84
- MNMD 54.37
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).